Pharmafile Logo
Pharmafocus logo
Advanced Search

Post-marketing surveillance

Showing 2 posts of 2 posts found.

EMA launches ‘black triangle’ post-marketing scheme

April 28, 2013
Sales and Marketing EMA, Post-marketing surveillance, black triangle, pharmacovigilance

The European Medicines Agency has unveiled its new ‘black triangle’ post-marketing surveillance system, and the list of drugs that will …

News

Ethical dilemmas add to ‘critical weaknesses’ In FDA safety monitoring

August 25, 2012
Sales and Marketing Avandia, Post-marketing surveillance, pharmacovigilance

Ethical challenges are central to continuing “critical weaknesses” in the FDA’s drug safety monitoring, according to a commentary by former …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026